Cytokinetics reported $-86752000 in Pre-Tax Profit for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US $ -112.57M 69.67M
Amgen AMGN:US $ 2727M 56M
Biogen BIIB:US $ 903.4M 316.6M
Brainstorm Cell Therapeutics BCLI:US $ -5.36M 1.83M
Bristol Myers Squibb BMY:US $ 5386M 595M
Capricor Therapeutics CAPR:US $ -7.82M 1.63M
Cytokinetics CYTK:US $ -86.75M 56.18M
Eisai 4523:JP Y -20779M 34669M
Exelixis EXEL:US $ 85.23M 32.79M
Genocea Biosciences GNCA:US $ -15.98M 2.7M
Geron GERN:US $ -30.1M 1.92M
Halozyme Therapeutics HALO:US $ 81.63M 20.43M
Intra Cellular Therapies ITCI:US $ -72.11M 13.62M
IONIS PHARMACEUT IONS:US $ -64M 289M
Merk MRK:US $ 6309M 1525M
Novartis NOVN:VX SF 3912M 230M
Pfizer PFE:US $ 11328M 4083M
Regeneron Pharmaceuticals REGN:US $ 1119.1M 1986M
Sanofi SAN:FP € 2965M 804M